Ashvinikumar V. Gavai

Enantioselective route to a key intermediate in the total synthesis of ginkgolide B

E. J. Corey, Ashvinikumar V. Gavai · Tetrahedron Letters · 1988 · 88 citations

Ginkgolide B, Enantioselective Route, Total Synthesis +6

Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors

Ashvinikumar V. Gavai, Claude Quesnelle, Derek Norris et al. · ACS Medicinal Chemistry Letters · 2015 · 88 citations · Full text

Solid Tumors, Pharmacotherapy, Tumor Biology +18

Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling

Tai W. Wong, Francis Y. Lee, Chiang Yu et al. · Clinical Cancer Research · 2006 · 78 citations

A (Z)-ethylidenecyclopentane annulation method. Total syntheses of (.+-.)-anhydrooplopanone, (.+-.)-oplopanone, and (.+-.)-8-epi-oplopanone

Edward Piers, Ashvinikumar V. Gavai · The Journal of Organic Chemistry · 1990 · 45 citations

Engineering, Heterocyclic, Altmetric Attention Score +10

Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17β-hydroxysteroid dehydrogenase type 3

Brian E. Fink, Ashvinikumar V. Gavai, John S. Tokarski et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 40 citations · Full text

Medicinal Chemistry, Aldehyde Dehydrogenase, Novel Series +7